Novel Life Science Reagents
All
Pharmaceutical Intermediates
Active Pharma Ingredients(API)
Drug Impurities
Novel Life Science Reagents
Natural Bulk Compounds
Botanical & Herbal Extracts
Health & Nutrition
Pharmaceutical Excipients
Product Name | CAS No. | Specification | Application | Registration |
Docosahexaenoic Acid (DHA) | 6217-54-5 | |||
Capsiate | 205687-01-0 | |||
St. John's Wort Extract, Hypericin 0.3% | 548-04-9(Hypericin) | 0.3% Hypericin; 50%+HPLC (synthetic) | ||
Lupeol | 545-47-1 | |||
Fidaxomicin | 873857-62-6 | |||
Ansamitocin P-3 | 66584-72-3 | |||
Artemisinin | 63968-64-9 | |||
Etanercept | 185243-69-0 | |||
Exenatide Acetate | 141732-76-5 | 98%Min. HPLC | ||
β-Thio-NAD (Thio-NAD) | 4090-29-3 | 95%Min.HPLC | ||
Vitamin D4 | 511-28-4 | 98%Min.HPLC | ||
SN-38 | 86639-52-3 | HPLC>99% | ||
Nomilin | 1063-77-0 | 98%Min.HPLC | ||
Aristolochic Acid A | 313-67-7 | 98%Min.HPLC | ||
Ercalcitriol (1α,25-Dihydroxyvitamin D2) | 60133-18-8 | 98%Min. | ||
Chlortetracycline Hydrochloride | 64-72-2 | EP 9.0 | ||
Fluocinolone Acetonide | 67-73-2 | BP2015 | ||
Genipin | 6902-77-8 | |||
Lamivudine | 134678-17-4 | USP38 | ||
Idarubicin Hydrochloride | 57852-57-0 |
Product Name | CAS No. | Specification | Application | Registration |
β-Thio-NAD (Thio-NAD) | 4090-29-3 | 95%Min.HPLC | ||
SN-38 | 86639-52-3 | HPLC>99% | ||
Chlortetracycline Hydrochloride | 64-72-2 | EP 9.0 | ||
Abiraterone | 154229-19-3 | |||
Cidofovir Anhydrous | 113852-37-2 | |||
Nintedanib | 656247-17-5 | |||
Sulfobutyl Ether-β-Cyclodextrin Sodium salt (SBE-β-CD) | 182410-00-0 | |||
(6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride | 69056-38-8 | In-House Standard | ||
tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-(isobutylamino)propyl]carbamate | 160232-08-6 | In-House Standard | ||
2',2'-Difluoro-2'-deoxycytidine-3',5'-dibenzoate; T9 | 134790-39-9 | In-House Standard | ||
Bumetanide | 28395-03-1 | |||
Leuprorelin Acetate | 74381-53-6 | |||
Gemcitabine Base | 95058-81-4 | |||
L-Biopterin | 22150-76-1 | In-House Standard | N/A |
Product Name | CAS No. | Specification | Application | Registration |
Fidaxomicin | 873857-62-6 | |||
Exenatide Acetate | 141732-76-5 | 98%Min. HPLC | ||
Fluocinolone Acetonide | 67-73-2 | BP2015 | ||
Lamivudine | 134678-17-4 | USP38 | ||
Idarubicin Hydrochloride | 57852-57-0 | |||
Daunorubicin Hydrochloride | 23541-50-6 | Antineoplastic Agents | ||
Epirubicin Hydrochloride | 56390-09-1 | Antineoplastic Agents | ||
Ixabepilone | 219989-84-1 | |||
Everolimus | 159351-69-6 | |||
Emtricitabine | 143491-57-0 | |||
Entecavir Monohydrate | 209216-23-9 | |||
Vismodegib (GDC-0449) | 879085-55-9 | |||
Regadenoson Monohydrate | 313348-27-5 | |||
Ulipristal Acetate | 126784-99-4 | |||
Tofacitinib (CP-690550) | 477600-75-2 | |||
Tofacitinib (CP-690550) Citrate | 540737-29-9 | |||
Abiraterone Acetate | 154229-18-2 | |||
Nelarabine | 121032-29-9 | |||
Bortezomib | 179324-69-7 | |||
Combretastatin A4 Phosphate (CA4P) Disodium Salt | 168555-66-6 |
Product Name | CAS No. | Specification | Application | Registration |
7-Epi-Paclitaxel (7-Epitaxol) | 105454-04-4 | In-House Standard | Paclitaxel EP Impurity E | N/A |
Abiraterone Isopropyl Ether; AB-IMP-13 | N A | In-House Standard | ||
Abiraterone Ethyl Ether; AB-IMP-12 | N A | In-House Standard |
Product Name | CAS No. | Specification | Application | Registration |
Capsiate | 205687-01-0 | |||
Ansamitocin P-3 | 66584-72-3 | |||
Etanercept | 185243-69-0 | |||
Vitamin D4 | 511-28-4 | 98%Min.HPLC | ||
Ercalcitriol (1α,25-Dihydroxyvitamin D2) | 60133-18-8 | 98%Min. | ||
Verteporfin | 129497-78-5 | |||
Brefeldin A | 20350-15-6 | |||
Cetuximab | 205923-56-4 | Antineoplastic Agent | ||
Trastuzumab | 180288-69-1 | Antineoplastic Agent | ||
ICG-001 | 847591-62-2 | 98%Min.HPLC | ||
Anakinra (IL-1Ra) | 143090-92-0 | Rheumatoid Arthritis | ||
Mertansine; DM 1 | 139504-50-0 | In-House Standard | ||
Temoporfin | 122341-38-2 | In-House Standard | ||
Y-27632 Dihydrochloride | 129830-38-2 | In-House Standard | ||
Resatorvid (TAK-242) | 243984-11-4 | In-House Standard |
Product Name | CAS No. | Specification | Application | Registration |
Lupeol | 545-47-1 | |||
Artemisinin | 63968-64-9 | |||
Nomilin | 1063-77-0 | 98%Min.HPLC | ||
Aristolochic Acid A | 313-67-7 | 98%Min.HPLC | ||
Genipin | 6902-77-8 | |||
Forskolin | 66575-29-9 | |||
Salidroside | 10338-51-9 | |||
EGCG | 989-51-5 | |||
Cycloastragenol | 78574-94-4 | |||
Astragaloside IV | 84687-43-4 | |||
Cyclopamine | 4449-51-8 | In-House Standard | ||
(+)-Bicuculline | 485-49-4 | In-House Standard |
Product Name | CAS No. | Specification | Application | Registration |
St. John's Wort Extract, Hypericin 0.3% | 548-04-9(Hypericin) | 0.3% Hypericin; 50%+HPLC (synthetic) |
Product Name | CAS No. | Specification | Application | Registration |
Docosahexaenoic Acid (DHA) | 6217-54-5 | |||
Vitamin B6 (Pyridoxine Hydrochloride) | 58-56-0 | |||
Ectoine | 96702-03-3 | 98%Min.HPLC | ||
Dipeptide Diaminobutyroyl Benzylamide Diacetate | 823202-99-9 | 98%Min. HPLC |
Product Name | CAS No. | Specification | Application | Registration |